Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Total Current Liabilities (2016 - 2026)

Updated

Grace Therapeutics' Total Current Liabilities was $1.61 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 29.6% from $1.25 million a year earlier and up 29.1% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Total Current Liabilities (2016 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Total Current Liabilities at Grace Therapeutics came in at $2.15 million, up 11.2% from FY2025.

  • Total Current Liabilities shows a five-year compound annual growth rate of 6.3% (FY2021 to FY2026).
  • In earlier fiscal years, Total Current Liabilities was $1.93 million in FY2025 (+14.6%), $1.68 million in FY2024 (-50.6%), $3.41 million in FY2023 (+4.6%) and $3.26 million in FY2022 (+106.5%).
  • Quarterly Total Current Liabilities has moved between $1.25 million (fiscal Q2 2026) and $3.81 million (fiscal Q2 2023) over five years.
  • Compared with a year earlier, Total Current Liabilities was higher in four of the last eight quarters, with an average decline of 9.8%.
  • The best year-over-year quarter for Total Current Liabilities over five years was fiscal Q4 2022 (growth of 106.5%); the worst was fiscal Q2 2024 (a decline of 63.3%).
  • Per Business Quant data, GRCE's Total Current Liabilities in the three fiscal quarters before Q2 2027 was $1.25 million (Q1 2027), $2.15 million (Q4 2026) and $1.28 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 47.00 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 55.46 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 43.10 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 28.80 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -31.27 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 12.00 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 31.73 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 1.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.61 Mn
Jun 30, 2026 1.25 Mn
Mar 31, 2026 2.15 Mn
Dec 31, 2025 1.28 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 2.32 Mn
Mar 31, 2025 1.93 Mn
Dec 31, 2024 1.97 Mn
Sep 30, 2024 2.67 Mn
Jun 30, 2024 2.60 Mn
Mar 31, 2024 1.68 Mn
Dec 31, 2023 1.77 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 1.97 Mn
Mar 31, 2023 3.41 Mn
Dec 31, 2022 3.43 Mn
Sep 30, 2022 3.81 Mn
Jun 30, 2022 3.71 Mn
Mar 31, 2022 3.26 Mn
Dec 31, 2021 2.90 Mn
API Access

Grace Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=GRCE&period=max&api_key=YOUR_API_KEY